Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes
Maria Spiliotaki(University of Cyprus), Sofia Agelaki(University of Crete)
Cited by 17
Related Papers
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
|Breast Cancer Research|2011|373
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer
|ESMO Open|2021|93